Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
Journal of Thoracic Disease|August 14, 2025
Combining recombinant human endostatin with third-generation EGFR-TKIs in advanced EGFR-sensitive mutant non-small cell lung cancerJinhong Chen, Hongxiang Huang, Peiyuan Zhong, et al.The Oncologist|September 15, 2021
Patient-Reported Outcomes with Selpercatinib Among Patients with RET Fusion-Positive Non-Small Cell Lung Cancer in the Phase I/II LIBRETTO-001 TrialAnna Minchom, Aaron C Tan, Erminia Massarelli, et al.Oncoimmunology|December 16, 2022
Bystander CD4+ T cells infiltrate human tumors and are phenotypically distinctShamin Li, Summer Zhuang, Antja Heit, et al.Asia-Pacific Journal of Clinical Oncology|September 30, 2017
Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancerAaron C Tan, Bob T Li, Kazi Nahar, et al.Cancer Research and Treatment|December 19, 2025
Utilization, Reimbursement, and Barriers to Accessing Sequencing Tests for Cancer Care in the Asia-Pacific Region: KSMO Initiatives to Address Cancer Care InequityOmali Pitiyarachchi, Aaron C Tan, Tawasapon Thambamroong, et al.Cold Spring Harbor Molecular Case Studies|January 4, 2020
Molecular and clonal evolution in recurrent metastatic gliosarcomaKevin J Anderson, Aaron C Tan, Jonathon Parkinson, et al.JTO Clinical and Research Reports|January 13, 2022
Clinical Characteristics and Outcomes in Advanced KRAS-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005)Jiyun Lee, Aaron C Tan, Siqin Zhou, et al.JTO Clinical and Research Reports|January 1, 2024
Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate MeasureStephanie P L Saw, Gek San Tan, Wei Chong Tan, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 11, 2021
Intratumoral CD39+CD8+ T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLCJoe Yeong, Lisda Suteja, Yannick Simoni, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2023
The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical PracticeAlex Broom, Leah Williams Veazey, Katherine Kenny, et al.Pageof 6